Maxcyte (MXCT) Other Non-Current Liabilities (2020 - 2026)

Maxcyte (MXCT) has 7 years of Other Non-Current Liabilities data on file, last reported at $262000.0 in Q1 2026.

• On a quarterly basis, Other Non-Current Liabilities fell 2.96% year-over-year to $262000.0 in Q1 2026; TTM through Mar 2026 was $262000.0, a 2.96% decrease from a year earlier, with the FY2025 full-year figure at $263000.0, down 4.01% from the prior year.
• Other Non-Current Liabilities for Q1 2026 stood at $262000.0, roughly flat from $263000.0 in the prior quarter.
• Over the last five years, Other Non-Current Liabilities for MXCT reached as high as $1.3 million in Q4 2022 and fell as low as $25000.0 in Q2 2025.
• Historically, Other Non-Current Liabilities has averaged $535618.8 across 5 years, with a median of $281000.0 in 2023.
• Across the five-year window, Other Non-Current Liabilities surged 232.93% in 2023 and plunged 91.94% in 2025, its largest moves.
• Year by year, Other Non-Current Liabilities stood at $1.3 million in 2022, then slumped by 78.56% to $283000.0 in 2023, then decreased by 3.18% to $274000.0 in 2024, then fell by 4.01% to $263000.0 in 2025, then dropped by 0.38% to $262000.0 in 2026.
• Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $262000.0 in Q1 2026, $263000.0 in Q4 2025, and $227000.0 in Q3 2025.